Skip to main content
Article thumbnail
Location of Repository

A distinct metabolic signature predicts development of fasting plasma glucose

By Manuela Hische, Abdelhalim Larhlimi, Franziska Schwarz, Antje Fischer-Rosinský, Thomas Bobbert, Anke Assmann, Gareth S Catchpole, Andreas FH Pfeiffer, Lothar Willmitzer, Joachim Selbig and Joachim Spranger
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3298809
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). A causal role for uric acid in fructose-induced metabolic syndrome.
    2. (2009). Abrogation of Hepatic ATP-Citrate Lyase Protects Against Fatty Liver and Ameliorates Hyperglycemia in Leptin Receptor-Deficient Mice. Hepatology
    3. (2011). Al-Mohanna FA: Effect of trans-fat, fructose and monosodium glutamate feeding on feline weight gain, Hische et al.
    4. (2003). Antiobesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice.
    5. (2004). Application of Breiman’s random forest to modeling structure-activity relationships of pharmaceutical molecules. In Multiple classifier systems, proceedings,
    6. (2011). Circumstantial evidence for a role of glutamine-synthetase in suicide. Medical Hypotheses
    7. (2002). Classification and Regression by randomForest.
    8. (2011). Colpan L: Routine enzymes in the monitoring of type 2 diabetes mellitus. Cell Biochemistry and Function
    9. (2010). Decision tree supported substructure prediction of metabolites from GC-MS profiles. Metabolomics
    10. (2010). Decision Trees as a simple-to-use and reliable tool to identify individuals with impaired glucose metabolism or type 2 diabetes mellitus.
    11. (1980). Diabetic Syndrome in the Chinese-Hamster Induced with Monosodium Glutamate. Experientia
    12. (2011). Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors.
    13. (2011). DM: S-Glutathionylation: From Molecular Mechanisms to Health Outcomes. Antioxidants & Redox Signaling
    14. (1976). Effects of Monosodium Glutamate Administration
    15. (2010). EK: Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies. Int J Alzheimers Dis
    16. (2006). Elisaf MS: Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism-Clinical and Experimental
    17. (2008). EM: A specific blend of intact protein rich in aspartate has strong postprandial glucose attenuating properties in rats.
    18. (2008). Endo S: ERK1 plays a critical protective role against N-methyl-D-aspartateinduced retinal injury.
    19. (2010). et al: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics
    20. (2006). Fernie AR: Gas chromatography mass spectrometry-based metabolite profiling in plants. Nat Protoc
    21. (2006). Fiehn O: Mass Spectrometry-Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors. Cancer Res
    22. (2008). Fiehn O: Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover. Mol Cancer
    23. (2011). Fortes ZB: Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: Role of NO and prostanoids. Nutrition Metabolism and Cardiovascular Diseases
    24. (2010). Genetics of obesity and type 2 diabetes.
    25. (2010). Genomic Medicine Genomics, Type 2 Diabetes, and Obesity.
    26. (2011). Gerszten RE: Metabolite profiles and the risk of developing diabetes. Nat Med
    27. (1974). Glutathione - Metabolism and Function via gamma-Glutamyl Cycle. Life Sciences
    28. (2005). Glycation-induced inactivation of aspartate aminotransferase, effect of uric acid. Molecular and Cellular Biochemistry
    29. (2008). Groop L: Clinical Risk Factors,
    30. (2011). Grp RS: Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women. Diabetes
    31. (1999). Higashino K: Effect of glucose on the plasma concentration and urinary excretion of uridine and purine bases. Metabolism-Clinical and Experimental
    32. (2011). Higazi AAR: Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate.
    33. (1990). Human Urate Oxidase Gene - Cloning and
    34. (2006). In Global Burden of Disease and Risk Factors. Edited by:
    35. (2007). Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomedicine & Pharmacotherapy
    36. (2010). JD: ATP-Citrate Lyase Reduction Mediates Palmitate-induced Apoptosis in Pancreatic Beta Cells.
    37. (2011). Lioudaki E, Ganotakis ES: Liver enzymes: potential cardiovascular risk markers? Current pharmaceutical design
    38. (2010). Lower succinyl-CoA:3-ketoacid-CoA transferase (SCOT) and ATP citrate lyase in pancreatic islets of a rat model of type 2 diabetes: Knockdown of SCOT inhibits insulin release in rat insulinoma cells. Archives of Biochemistry and Biophysics
    39. (1981). Metabolic basis for disorders of purine nucleotide degradation. Metabolism-Clinical and Experimental
    40. (2006). Miyamo K: Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Experimental Animals
    41. (1999). Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes
    42. (2011). Ning G: Elevated serum gamma-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese. Endocrine
    43. (2011). No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia
    44. (1998). Obesity induced by neonatal monosodium glutamate treatment in spontaneously hypertensive rats: An animal model of multiple risk factors. Hypertension Research-Clinical and Experimental
    45. (2011). Oresic M: Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res
    46. (2011). Q: The association of gamma-glutamyltransferase and C-reactive protein with IFG/IGT in Chinese adults in Qingdao, China. Clinica Chimica Acta
    47. (2011). Qin Xz, Liu Yh, Ding Ht, Han Sm, Xu Cl, Zhu Gj: High prevalence of coexisting prehypertension and prediabetes among healthy adults in northern and northeastern China. BMC Public Health
    48. (2001). Random Forests.
    49. (2010). Reduced Activity and Expression of Mitochondrial Citrate Carrier in Streptozotocin-Induced Diabetic Rats. Endocrinology
    50. (2005). Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: Evidence for an intrinsic oxidative enzyme defect. Biochimica et Biophysica Acta-Molecular Basis of Disease
    51. (2002). RG: Crucial problems in regression modelling and their solutions. Analyst
    52. (2000). Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. J Clin Endocrinol Metab
    53. (2009). Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score - the CoLaus Study. Diabetologia
    54. (2009). RJ: Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry.
    55. (2011). S: Metabolic profiling reveals key metabolic features of renal cell carcinoma.
    56. (2011). Sesti G: One-hour post-load plasma glucose levels are associated with elevated liver enzymes. Nutrition Metabolism and Cardiovascular Diseases
    57. (1998). Shared biochemical properties of glucotoxicity and lipotoxicity in islets decrease citrate synthase activity and increase phosphofructokinase activity. Diabetes
    58. (2011). SK: Oxidative stress and diabetes mellitus. Clinical Chemistry and Laboratory Medicine
    59. (2009). Sone H: Association Between Serum Uric Acid and Development of Type 2 Diabetes. Diabetes Care
    60. (2001). Statistical modeling: The two cultures. Statistical Science
    61. (2004). Szutowicz A: The role of adenosine triphosphate-citrate lyase in the metabolism of acetylcoenzyme A and function of blood platelets in diabetes mellitus. Metabolism-Clinical and Experimental
    62. (2009). TargetSearch - a Bioconductor package for the efficient preprocessing of GC-MS metabolite profiling data.
    63. (2003). The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care
    64. (2009). The Elements of Statistical Learning
    65. (2007). The Golm Metabolome Database: a database for GC-MS based metabolite profiling.
    66. (2009). The Mitochondrial Citrate Carrier: Metabolic Role and Regulation of its Activity and Expression. IUBMB Life
    67. (1988). Xanthine and Uridine in Body-Fluids, Indicators of ATP Depletion.
    68. (1992). Y: Alterations in Acetyl Coenzyme-A Carboxylase Activities in Voles and Mice Treated with Monosodium Aspartate.
    69. (1994). YS: Induction of hepatic ATPcitrate lyase by insulin in diabetic rat-effects of insulin on the contents of enzyme and its mRNA in cytosol, and the transcriptional activity in nuclei. Yonsei medical journal

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.